Business
Universal Ibogaine Announces Expansion of Executive Team andGrant of Stock Options
(TheNewswire) Calgary, AB - TheNewswire – December 2, 2021...
About this update from Universal Ibogaine Inc
[{"type":"text","content":"Universal Ibogaine Announces Expansion of Executive Team andGrant of Stock Options\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n Calgary, AB -\n \n \n TheNewswire\n \n \n – December 2, 2021 –\nUniversal Ibogaine Inc. (TSXV:IBO) (“\n \n \n UI\n \n \n ” or the\n“\n \n \n Company\n \n \n ”), a life sciences company with a mission to research and\ndeliver medicalized ibogaine-centered addiction care, is pleased to\nannounce an expansion of its’ Executive team, and welcomes Nick\nKaros as its new Director – Capital Markets.\n \n \n \n \n Mr. Karos is based in Los Angeles, USA, and is a\nseasoned financier.  His career includes senior roles with US\ninvestment banks, including serving at Piper Jaffray as head of Nasdaq\nTrading and Agency Services, and most recently as CEO of Private\nTrading Group, which has provided business development and capital\nraising services for several successful start-up ventures.\n \n \n \n \n Mr. Karos’ mandate will include expanding awareness\nof UI in the US-based investment community (including institutional\ninvestors, family offices, high net worth individuals and investment\nadvisors), securing sources of expansion capital, as well as\nidentifying business development opportunities in the addiction\ntreatment industry.  UI is currently in the process of finalizing an\napplication to be listed for trading in the USA on the OTC QB\nmarket.\n \n \n \n \n UI also advises that it has granted incentive stock\noptions (“\n \n \n Options\n \n \n ”) to members of its recently\nexpanded Executive team, as well as to several key, long-serving\nconsultants to UI, and two new members of its’ Board of Directors\nwho joined UI effective October 18, 2021, as follows:\n \n \n \n \n \n \n \n Chief Clinics Officer (Ian Rabb, joined UI November\n15)\n \n \n \n \n \n \n 3,000,000\n \n \n \n \n \n \n \n \n Chief Financial Officer (Greg Leavens)\n \n \n \n \n \n \n 2,000,000\n \n \n \n \n \n \n \n \n Director – Capital Markets (Nick Karos)\n \n \n \n \n \n \n 2,000,000\n \n \n \n \n \n \n \n \n Board members (David Danziger and Anthony DeCristofaro,\njoined UI October 18)\n \n \n \n \n \n \n 400,000\n \n \n \n \n \n \n \n \n Consultants\n \n \n \n \n \n \n 1,450,000\n \n \n \n \n \n \n \n \n \n \n 8,850,000\n \...